MRI vs. Ultrasound for Liver Cancer Detection in Cirrhosis
Part of Brain & nervous system, Cancer, Digestive system clinical trials.
This study compares MRI and ultrasound to see which is better at finding liver cancer early in people with liver cirrhosis. It also looks at body composition and other factors that could lead to worsening liver function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with liver cirrhosis (scarring of the liver).
- You must be between 18 and 84 years old.
- You must be able to have an MRI (no metal implants, pacemaker, or severe claustrophobia).
- You cannot be pregnant.
- You cannot have certain other liver conditions like primary sclerosing cholangitis (a bile duct disease) or congenital liver fibrosis.
- You cannot have had a liver transplant or a previous diagnosis of liver cancer (hepatocellular carcinoma).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a quicker MRI screening approach for people with cirrhosis to look for liver cancer early. It may help make liver cancer checkups faster and easier while still finding cancers when they are small.
This study compares two imaging methods, ultrasound and MRI, to see which is better at finding liver cancer early in people who are at high risk. Early detection could lead to more effective treatment and better outcomes.
This study tests a new type of MRI that can look at the liver in more detail. It compares images from people with liver cancer and healthy people to see if it can help doctors better understand or detect the disease.
This trial uses special MRI scans to learn more about liver cancer (hepatocellular carcinoma) before and during treatment with TACE or SIRT. It may help doctors better understand how the tumor responds to therapy.
This trial compares two types of scans to see which detects liver cancer better in people at high risk. You would receive either an MRI with contrast or an ultrasound every 6 months to monitor for liver cancer.
This study compares a shorter, non-contrast MRI and ultrasound to monitor for liver cancer in people with cirrhosis whose ultrasound images aren’t clear enough. It aims to see which method works better and may help you get safer, more reliable follow-up.
Hear when a new Liver Cirrhoses trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.